Continuum Advisory’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-403
Closed -$3.21K 1440
2025
Q1
$3.21K Sell
403
-120
-23% -$1.21K ﹤0.01% 1207
2024
Q4
$4.75K Hold
523
﹤0.01% 1149
2024
Q3
$4.69K Buy
523
+88
+20% +$728 ﹤0.01% 1176
2024
Q2
$4.25K Sell
435
-19
-4% -$232 ﹤0.01% 1109
2024
Q1
$5.56K Buy
+454
New +$8.24K ﹤0.01% 1048

Other funds holding TDOC

Continuum Advisory's TDOC Position: Q2 2025 in Review

Continuum Advisory sold out of Teladoc Health (TDOC) in Q2 2025, closing a stake of 403 shares — an estimated $3.21K sold.

Continuum Advisory first reported a position in TDOC in Q1 2024 and held it in 5 quarters. The position peaked at $5.56K in Q1 2024. 358 funds tracked by Wall St. Rank hold TDOC as of Q2 2025.

  • Continuum Advisory reported no remaining Teladoc Health position as of Q2 2025 after selling out during the quarter.
  • Continuum Advisory sold 403 Teladoc Health shares in Q2 2025, an estimated $3.21K.
  • Continuum Advisory first reported a position in Teladoc Health in Q1 2024 and held it in 5 quarters.
  • Continuum Advisory's Teladoc Health position peaked at $5.56K in Q1 2024.
  • 358 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2025.

Based on Continuum Advisory's 13F filing for Q2 2025, filed 13 Aug 2025.